3B BlackBio Dx Limited Files SEBI Compliance Certificate for Q4FY26

1 min read     Updated on 06 Apr 2026, 11:07 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

3B BlackBio Dx Limited submitted its mandatory quarterly certificate under SEBI Depositories Regulations for Q4FY26 to BSE Limited on April 6, 2026. The filing, signed by Whole Time Director Nikhil Kuber Dubey, includes confirmation from RTA Adroit Corporate Services validating proper dematerialization processes and compliance with regulatory requirements for securities handling during the quarter ended March 31, 2026.

powered bylight_fuzz_icon
37042676

*this image is generated using AI for illustrative purposes only.

3B BlackBio Dx Limited has filed its quarterly compliance certificate with BSE Limited, fulfilling mandatory regulatory requirements under SEBI Depositories and Participants Regulations for the quarter ended March 31, 2026.

Regulatory Compliance Filing

The company submitted the certificate on April 6, 2026, in compliance with Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. The filing was signed by Nikhil Kuber Dubey, Whole Time Director (DIN: 00538049), and addressed to the Department of Corporate Relations at BSE Limited.

Filing Details: Information
Quarter Ended: March 31, 2026
Filing Date: April 6, 2026
Reference Number: P-66/2026-27/3
Signatory: Nikhil Kuber Dubey, Whole Time Director
DIN: 00538049

RTA Confirmation Certificate

Adroit Corporate Services Pvt. Ltd., serving as the company's Registrar and Share Transfer Agent, provided the confirmation certificate dated April 1, 2026. The RTA confirmed that securities received from depository participants for dematerialization during Q4FY26 were properly processed and confirmed to the depositories.

Key Compliance Confirmations

The RTA certificate validates several critical compliance aspects:

  • Securities received for dematerialization were confirmed (accepted/rejected) to depositories
  • Securities comprised in certificates have been listed on stock exchanges where earlier issued securities are listed
  • Security certificates received for dematerialization have been mutilated and cancelled after due verification
  • Depository names have been substituted in the register of members as registered owners within 15 days

Corporate Structure

The filing identifies the company as 3B BlackBio Dx Limited (Formerly, Kilpest India Limited), indicating a recent corporate restructuring or name change. The company maintains its registered operations from Bhopal, Madhya Pradesh.

This quarterly certification demonstrates the company's adherence to SEBI's regulatory framework governing depositories and participants, ensuring transparent and compliant securities handling processes throughout Q4FY26.

Historical Stock Returns for 3B BlackBio DX

1 Day5 Days1 Month6 Months1 Year5 Years
+4.23%+8.79%-2.16%-11.90%-27.32%+262.27%

What strategic business changes prompted 3B BlackBio Dx Limited's recent name change from Kilpest India Limited?

How might the company's transition into biotechnology diagnostics impact its financial performance in upcoming quarters?

Will 3B BlackBio Dx Limited require additional regulatory approvals from healthcare authorities given its apparent shift to biotech operations?

3B BlackBio Dx Limited Promoters Declare No Share Encumbrance for FY2026

1 min read     Updated on 04 Apr 2026, 04:31 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

3B BlackBio Dx Limited has filed its mandatory annual disclosure under SEBI Takeover Regulations 31(4), confirming that promoters maintained no encumbrance or pledge of shares during FY2026. The declaration was submitted by promoter Nikhil Kuber Dubey on behalf of the entire promoter group, demonstrating clean shareholding structure and regulatory compliance. This transparency measure reinforces the company's commitment to corporate governance standards and investor protection requirements.

powered bylight_fuzz_icon
36846063

*this image is generated using AI for illustrative purposes only.

3B BlackBio Dx Limited has submitted its annual regulatory disclosure to BSE Limited, confirming that its promoter group maintained clean shareholding throughout the financial year ended March 31, 2026. The disclosure, filed under SEBI Takeover Regulations, demonstrates the company's commitment to regulatory compliance and transparency.

Regulatory Compliance Declaration

The disclosure was filed by Nikhil Kuber Dubey, a key promoter of the company, who submitted the declaration on behalf of the entire promoter and promoter group along with persons acting in concert. Company Secretary and Compliance Officer Navneet Kaur (ACS No.29130) facilitated the filing to BSE Limited on April 4, 2026.

Filing Details: Information
Regulation: SEBI Takeover Regulations 31(4)
Financial Year: Ended March 31, 2026
Filing Date: April 4, 2026
Promoter Representative: Nikhil Kuber Dubey
Company Secretary: Navneet Kaur (ACS No.29130)

Share Encumbrance Status

The promoter group has declared that no encumbrance or pledge of shares was made directly or indirectly during the financial year ended March 31, 2026. This declaration covers all members of the promoter and promoter group, including persons acting in concert with the company.

The clean shareholding status indicates that promoters have maintained full ownership rights over their shareholding without creating any security interests or pledges against their equity stakes. This transparency measure is mandated under SEBI regulations to protect investor interests and maintain market integrity.

Corporate Governance Framework

The filing represents part of the company's ongoing compliance with SEBI's substantial acquisition and takeover regulations. These annual disclosures ensure that stakeholders remain informed about any changes in promoter shareholding patterns and encumbrance status.

Compliance Aspect: Status
Share Encumbrance: Nil
Share Pledge: Nil
Regulatory Compliance: Complete
Disclosure Timeline: Within prescribed limits

The company operates from its registered office at 7C, Industrial Area, Govindpura, Bhopal-462023, and the disclosure has been copied to the Chairman of the Audit Committee as part of internal governance protocols. This filing reinforces the company's commitment to maintaining transparent corporate governance standards and regulatory compliance.

Historical Stock Returns for 3B BlackBio DX

1 Day5 Days1 Month6 Months1 Year5 Years
+4.23%+8.79%-2.16%-11.90%-27.32%+262.27%

Will 3B BlackBio Dx consider raising capital through promoter share pledging in the upcoming financial year to fund expansion plans?

How might the company's clean shareholding status impact its credit rating and ability to secure institutional funding for future projects?

What strategic acquisitions or partnerships could 3B BlackBio Dx pursue now that promoter shares remain unencumbered?

More News on 3B BlackBio DX

1 Year Returns:-27.32%